SE469171B - 2-tioxo-5-pyrimidinkarboxamider, farmaceutisk komposition innehaallande dessa samt foerfarande foer framstaellning daerav - Google Patents

2-tioxo-5-pyrimidinkarboxamider, farmaceutisk komposition innehaallande dessa samt foerfarande foer framstaellning daerav

Info

Publication number
SE469171B
SE469171B SE8406450A SE8406450A SE469171B SE 469171 B SE469171 B SE 469171B SE 8406450 A SE8406450 A SE 8406450A SE 8406450 A SE8406450 A SE 8406450A SE 469171 B SE469171 B SE 469171B
Authority
SE
Sweden
Prior art keywords
pyrimidinecarboxamide
thioxo
tetrahydro
hydroxy
oxo
Prior art date
Application number
SE8406450A
Other languages
English (en)
Swedish (sv)
Other versions
SE8406450L (sv
SE8406450D0 (sv
Inventor
A D Brewer
J A Minatelli
Original Assignee
Uniroyal Chem Co Inc
Uniroyal Chemical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniroyal Chem Co Inc, Uniroyal Chemical Ltd filed Critical Uniroyal Chem Co Inc
Publication of SE8406450D0 publication Critical patent/SE8406450D0/xx
Publication of SE8406450L publication Critical patent/SE8406450L/xx
Publication of SE469171B publication Critical patent/SE469171B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/557—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. orotic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms
    • C07D239/66—Thiobarbituric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8406450A 1983-12-19 1984-12-18 2-tioxo-5-pyrimidinkarboxamider, farmaceutisk komposition innehaallande dessa samt foerfarande foer framstaellning daerav SE469171B (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US56269383A 1983-12-19 1983-12-19
US66526784A 1984-10-26 1984-10-26
US66520184A 1984-10-26 1984-10-26

Publications (3)

Publication Number Publication Date
SE8406450D0 SE8406450D0 (sv) 1984-12-18
SE8406450L SE8406450L (sv) 1985-06-20
SE469171B true SE469171B (sv) 1993-05-24

Family

ID=27415896

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8406450A SE469171B (sv) 1983-12-19 1984-12-18 2-tioxo-5-pyrimidinkarboxamider, farmaceutisk komposition innehaallande dessa samt foerfarande foer framstaellning daerav

Country Status (19)

Country Link
US (1) US4634707A (enExample)
JP (1) JPH0660164B2 (enExample)
AT (1) AT394194B (enExample)
AU (1) AU580746B2 (enExample)
BE (1) BE901301A (enExample)
CH (1) CH671225A5 (enExample)
DE (1) DE3446371A1 (enExample)
DK (1) DK164055C (enExample)
ES (1) ES8606296A1 (enExample)
FR (1) FR2557108B1 (enExample)
GB (1) GB2152047B (enExample)
GR (1) GR82494B (enExample)
IE (1) IE57675B1 (enExample)
IL (1) IL73840A (enExample)
IT (1) IT1213257B (enExample)
LU (1) LU85696A1 (enExample)
NL (1) NL8403856A (enExample)
NZ (2) NZ210599A (enExample)
SE (1) SE469171B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2145087B (en) * 1983-08-19 1987-02-04 Ciba Geigy Ag Barbituric acid derivatives
EP0167491A3 (de) * 1984-07-06 1986-12-30 Ciba-Geigy Ag Thiobarbitursäurederivate
GB2171099B (en) * 1985-02-15 1988-10-19 Ciba Geigy Ag 5-(azolyloxphenylcarbamoyl)barbituric acid derivatives as anthelmintics
US4636508A (en) * 1985-04-22 1987-01-13 Uniroyal Chemical Company, Inc. 5-pyrimidinecarboxyamides and treatment of leukemia therewith
EP0202823A3 (en) * 1985-05-17 1987-11-19 Uniroyal Limited Purification of 5-pyrimidinecarboxamides
US4845217A (en) * 1985-05-17 1989-07-04 Uniroyal Chemical Ltd./Ltee Purification of 5-pyrimidinecarboxamides
US4880811A (en) * 1987-06-24 1989-11-14 Memorial Hospital For Cancer And Allied Diseases Use of C-5 mono-substituted barbiturates to treat disorders of uric acid metabolism
US4920126A (en) * 1988-05-10 1990-04-24 Uniroyal Chemical Ltd/Uniroyal Chemical Ltee Barbituric acid derivative and treatment of leukemia and tumors therewith
WO1991013623A1 (en) * 1990-03-09 1991-09-19 Memorial Hospital For Cancer And Allied Diseases C-5 mono-substituted barbiturates in combination with therapeutic agents and uses thereof
EP1276728A2 (en) 2000-04-24 2003-01-22 ARYx Therapeutics Ultrashort acting hypnotic barbiturates
US10093631B2 (en) * 2014-02-14 2018-10-09 Acquist Llc Bifunctional compounds and use for reducing uric acid levels
CN107108526A (zh) * 2015-01-22 2017-08-29 R·P·小沃勒尔 双功能化合物及用于降低尿酸水平的用途
TWI771303B (zh) 2016-06-30 2022-07-21 美商艾克奎斯特有限責任公司 化合物及其於降低尿酸位準之用途(一)
EP3481819B1 (en) 2016-07-06 2022-06-01 Acquist LLC Compounds and their use for reducing uric acid levels
IT201700028709A1 (it) 2017-03-15 2018-09-15 Fondazione St Italiano Tecnologia Acidi-5-carbossamide-2-tiobarbiturici e loro uso come medicamenti

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH602664A5 (en) * 1973-06-14 1978-07-31 Sandoz Ag 2-Tert. amino-alkylamino-pyrimidine derivs.
DE2405732A1 (de) * 1974-02-07 1975-08-21 Bayer Ag Ekto- und endoparasitenmittel
DE2405733C2 (de) * 1974-02-07 1984-12-13 Bayer Ag, 5090 Leverkusen Amidocarbonylthiobarbitursäurederivate und deren Salze, Verfahren zu ihrer Herstellung sowie ihre Verwendung zur Bekämpfung von Insekten, Milben und Pilzen
CH614944A5 (en) * 1974-04-16 1979-12-28 Sandoz Ag Process for the preparation of novel pyrimidine derivatives
PL103086B1 (pl) * 1976-05-06 1979-05-31 Ciba Geigy Ag Srodek owadobojczy
CH616563A5 (en) * 1976-05-06 1980-04-15 Ciba Geigy Ag Pesticide containing a 5-phenylcarbamoylbarbituric acid as active ingredient
DE2624856A1 (de) * 1976-06-03 1977-12-22 Hoechst Ag 2-thiohexahydropyrimidin-4,6-dion-derivate und verfahren zu ihrer herstellung
US4283444A (en) * 1978-09-12 1981-08-11 Ciba-Geigy Corporation Method of protecting keratinous material from attack by insects that feed on keratin by treatment with 5-phenylcarbamoylbarbituric acid compounds
EP0010941B1 (en) * 1978-10-30 1982-05-12 Fujisawa Pharmaceutical Co., Ltd. 5-fluorouracil derivatives, preparation thereof and their pharmaceutical compositions
US4349552A (en) * 1978-10-30 1982-09-14 Fujisawa Pharmaceutical Company, Ltd. 5-Fluorouracil derivatives, and their pharmaceutical compositions
CH654720A5 (de) * 1981-09-03 1986-03-14 Ciba Geigy Ag Lagerstabile mottenschutzformulierungen.
US4410524A (en) * 1982-06-01 1983-10-18 American Cyanamid Company Novel 1,4-bis(substituted-amino)-5,8-dihydroxyanthraquinones and leuco bases thereof
GB2126582B (en) * 1982-08-26 1986-03-05 Ciba Geigy Ag Phenyl carbamoyl barbituric acid anthelmintics
CH658770A5 (de) * 1982-08-26 1986-12-15 Ciba Geigy Ag Motten- und kaeferschutzmittel.
ZA849819B (en) * 1983-12-19 1985-07-31 Uniroyal Inc 5-pyrimidinecarboxamides and thiocarboxamides and treatment of leukemia and tumors therewith
EP0167491A3 (de) * 1984-07-06 1986-12-30 Ciba-Geigy Ag Thiobarbitursäurederivate

Also Published As

Publication number Publication date
SE8406450L (sv) 1985-06-20
US4634707A (en) 1987-01-06
DE3446371C2 (enExample) 1990-08-16
NL8403856A (nl) 1985-07-16
DK609184A (da) 1985-06-20
DE3446371A1 (de) 1985-06-27
GB2152047B (en) 1988-04-27
ES8606296A1 (es) 1986-04-16
IE57675B1 (en) 1993-02-24
IL73840A (en) 1988-11-15
GB8432112D0 (en) 1985-01-30
JPS62174058A (ja) 1987-07-30
IT8424104A0 (it) 1984-12-18
AT394194B (de) 1992-02-10
JPH0660164B2 (ja) 1994-08-10
IL73840A0 (en) 1985-03-31
SE8406450D0 (sv) 1984-12-18
FR2557108A1 (fr) 1985-06-28
LU85696A1 (fr) 1985-09-12
NZ220399A (en) 1987-09-30
GB2152047A (en) 1985-07-31
DK164055C (da) 1992-09-28
CH671225A5 (enExample) 1989-08-15
GR82494B (en) 1985-04-19
AU3690884A (en) 1985-07-04
NZ210599A (en) 1987-09-30
DK609184D0 (da) 1984-12-18
ATA402684A (de) 1991-08-15
BE901301A (fr) 1985-06-18
IE843237L (en) 1985-06-19
ES538829A0 (es) 1986-04-16
FR2557108B1 (fr) 1988-11-18
DK164055B (da) 1992-05-04
IT1213257B (it) 1989-12-14
AU580746B2 (en) 1989-02-02

Similar Documents

Publication Publication Date Title
US3236857A (en) 2-(phenyl-amino)-1, 3-diazacyclopentene-(2) substitution products
DE69202243T2 (de) 2,4-Diaminochinazolin-Derivate, um die Antitumorwirkung zu erhöhen.
CA1330436C (en) Water soluble, antineoplastic derivatives of taxol
US5519155A (en) Platinum complexes
EP1392662A1 (de) Cdk inhibitorische pyrimidine, deren herstellung und verwendung als arzneimittel
EP0134922B1 (de) Neue 2-Piperazino-pteridine, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3446371C2 (enExample)
US7074925B1 (en) N-substituted derivatives of 5-oxyiminobarbituric acid
EP0877022B1 (en) Sulfonylpyrimidine derivatives with anticancer activity
US4636508A (en) 5-pyrimidinecarboxyamides and treatment of leukemia therewith
KR900003499B1 (ko) 퀴놀린계 화합물, 그의 제조방법 및 그 화합물을 약효성분으로 함유하는 항암제
DE69623760T2 (de) Kaliumionen-kanal-blocker
DE69320844T2 (de) Antitumorpräparate und Verfahren zur Behandlung
NO180194B (no) 6-[X-(2-hydroksyetyl)aminoalkylÅ-5,11-diokso-5,6-dihydro-11-H-indeno[1,2-cÅisokinoliner og anvendelse derav til fremstilling av medikamenter, samt medikament inneholdende slike kinoliner
CH642668A5 (de) 2,6-diaminonebularine, verfahren zu deren herstellung und sie enthaltende pharmazeutische praeparate.
DE69815380T2 (de) N,n'-bis (sulfonyl) hydrazine die als antineoplastische mittel nützlich sind
JPH0441145B2 (enExample)
DE69403695T2 (de) Indol-sulfonamide als Antitumormittel
CA2294243C (en) Novel cyanoaziridines for treating cancer
US2928768A (en) Use of substituted amino-formoguanamines in diuretic therapy
US6197804B1 (en) 4,5-azolo-oxindoles
RU2820661C1 (ru) (e)-5-амино-2-оксо-1-(2-(нафталин-2-ил)-2-оксоэтилиден)-1,2,6,7,8,9-гексагидробензо[4,5]тиено[3,2-e]пирроло[1,2-a]пиримидин-3-карбоксамид, обладающий противораковой активностью в терапии рака молочной железы
US4218465A (en) Glyoxylic acid hydrocarbylsulfonylhydrazones and therapeutic compositions
EP0186454B1 (en) 6-purinyl n-(2-chloroethyl) carbamate and thiocarbamate, a process for their preparation and use thereof
CA1256861A (en) 5-pyrimidinecarboxamides and treatment of leukemia and tumors therewith

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8406450-0

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8406450-0

Format of ref document f/p: F